Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
- DOI
- 10.3389/fimmu.2023.1134178
- Published
- 2023-04-28
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2023.1134178,
title = {Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome},
author = {Limor Rubin and Aviv Talmon and Yaarit Ribak and Asa Kessler and Yossi Martin and Tal Keidar Haran and Oded Shamriz and Irit Adini and Yuval Tal},
year = {2023},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2023.1134178},
url = {https://doi.org/10.3389/fimmu.2023.1134178}
}RIS
TY - JOUR TI - Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome AU - Limor Rubin AU - Aviv Talmon AU - Yaarit Ribak AU - Asa Kessler AU - Yossi Martin AU - Tal Keidar Haran AU - Oded Shamriz AU - Irit Adini AU - Yuval Tal PY - 2023 JO - Frontiers in Immunology DO - 10.3389/fimmu.2023.1134178 UR - https://doi.org/10.3389/fimmu.2023.1134178 ER -
APA
Rubin, L., Talmon, A., Ribak, Y., Kessler, A., Martin, Y., Haran, T. K., Shamriz, O., Adini, I., & Tal, Y. (2023). Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1134178
Source records
- crossref · retrieved 2026-09-27T10:52:11.001Z